Serving startups and emerging-growth companies

REPRESENATIVE TRANSACTIONS

A summary of selected transactions that illustrate Devonshire's merger, acquisition and financing capabilities include:

  • For Year 2000 Software Company, prepared business plan and raised $2 million in expansion financing.
  • For a web site development company, assisted with aggressive roll-up acquisition program. Completed seven acquisitions and successful public offering.
  • For a UK based information monitoring company, planning, financing and executing a roll-up/acquisition strategy.
  • For a large publicly traded electronics company, acted as financial advisor assisting with the planning of a major financing incorporating the carve-out of three divisions and a public offering.
  • For a U.S. publicly traded drug company, assisted with the acquisition of a U.K. based chemical company and raised $150 million to finance the acquisition;
  • For a publicly traded Massachusetts based drug company, assisted with the company's plans to spin-off one of its divisions, acquire a U.K. based chemical manufacturing company, merge the two companies, and raise $150 million finance the acquisition.
  • For a start-up Internet software company, assisted in raising $4 million first round venture capital financing and served as CFO for the company. One year later, the company was sold to Microsoft for $138 million.
  • For a U.S. based publicly traded gaming supply company, assisted with the acquisition and financing of a privately held Canadian company in the same business, conducted a valuation of both companies, negotiated terms, arranged a $50 million acquisition financing package consisting of $20 million of equity and $30 million of bank debt.
  • For a major electronics manufacturing company, assisted with the formulation of the strategy for the acquisition of a broad range of software companies, identifying candidate companies, carrying out the company valuations and assisting with structuring and negotiations;
  • For a major semiconductor company, assisted with the acquisition of a company in a complementary business, including evaluation, deal structure, valuation and negotiations;
  • For a diversified holding company, assisted with the sale of the regional home health care division of the company.
  • For a major health care consulting firm, initiated and oversaw several new business ventures and partnerships bringing advanced systems technology to bear on their core consulting business.
  • Advised the management of the asset management subsidiary of a major financial services company regarding an outright sale versus a management buyout of the subsidiary.
  • Advised a large mutual fund company regarding the purchase of a publicly traded funds management firm.
  • Advised a Fortune 100 technology company regarding partnering with an advanced software vendor.
  • Advised (another) Fortune 100 technology company regarding the establishment of a series of joint development partnerships for several emerging technologies.
  • Advised a Japanese software company regarding the acquisition of a minority interest in a complementary American company.
  • Advised a Japanese industrial equipment manufacturer regarding the acquisition of an American supplier.
  • Advised a ceramics manufacturer in the acquisition of a manufacturer of a complementary product line.
  • Advised a major industrial equipment manufacturer regarding the sale of a manufacturing division. Solicitation was global.
  • Advised an investment group acquiring a publicly traded technology company.
  • Advised a Japanese precision parts manufacturer in the acquisition of complementary businesses in both the United States and Europe.
  • Advised a European diversified manufacturer in the acquisition of an American industrial equipment manufacturer.
  • Advised an asset management company in the acquisition and operational integration of a complementary business.
  • In conjunction with Nikko Securities, Inc., advised a major Japanese precision parts manufacturer on the acquisition of American and Swiss manufacturing companies.
  • Represented several early-stage biotechnology companies seeking major company partners, particularly in Japan.
  • On behalf of several large investment banking firms, conducted "due diligence" assignments with regard to potential acquisitions in a broad range of industries, but with particular emphasis on manufacturing companies.